N

NLS Pharmaceutics Ltd
D

NLSP

3.24000
USD
-0.25
(-7.16%)
Market Closed
Volume
3,695
EPS
0
Div Yield
0
P/E
-0
Market Cap
3,797,115
OverviewSignalsIdeasNews
Related Instruments
    B
    BGNE
    -4.190
    (-2.51%)
    162.540 USD
    B
    BLUE
    -0.06000
    (-5.26%)
    1.08000 USD
    F
    FATE
    -0.46000
    (-8.61%)
    4.88000 USD
    G
    GH
    -1.770
    (-5.04%)
    33.380 USD
    I
    IOVA
    -0.58000
    (-6.64%)
    8.16000 USD
    MRNA
    -25.020
    (-20.99%)
    94.160 USD
    N
    NVTA
    0
    (0%)
    0.000000 USD
    R
    RARE
    -0.870
    (-1.93%)
    44.140 USD
    VRTX
    9.75
    (1.97%)
    484.2 USD
    More
News

Title: Nls Pharmaceutics Ltd

Sector: Healthcare
Industry: Biotechnology
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.